The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort

被引:7
|
作者
Theron, B. T. [1 ]
Padmanabhan, H. [1 ]
Aladin, H. [1 ]
Smith, P. [1 ]
Campbell, E. [1 ]
Nightingale, P. [2 ]
Cooper, B. T. [3 ]
Trudgill, N. J. [1 ]
机构
[1] Sandwell Gen Hosp, Dept Gastroenterol, West Bromwich, England
[2] Univ Hosp Birmingham Fdn Trust, Welcome Trust Clin Res Facil, Birmingham, W Midlands, England
[3] City Hosp, Gastroenterol Unit, Birmingham, W Midlands, England
关键词
Barrett's oesophagus; oesophageal adenocarcinoma; endoscopic surveillance; dysplasia; Barrett's length; mortality; MALIGNANT PROGRESSION; DYSPLASIA; MORTALITY; SURVEILLANCE; CANCER; POPULATION; SURVIVAL; SYMPTOMS; OBESITY; REFLUX;
D O I
10.1177/2050640616632419
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Varying rates of oesophageal adenocarcinoma (OAC) complicating Barrett's oesophagus (BO) have been reported. Recent studies and meta-analyses suggest a lower incidence, questioning the value of endoscopic surveillance. Aim: We aimed to retrospectively examine the rate of OAC, risk factors and causes of death in a prospectively recruited BO cohort. Methods: Data from patients with BO from a cohort from 1982-2007 were studied. Patients were subdivided into surveyed, failed to attend surveillance and unfit for surveillance. Standardised mortality ratios (SMR) were calculated for common causes of death. Cox proportional hazards models were used to determine which factors were associated with progression to OAC. Results: In total, 671 BO patients (61% male) were studied; 37 (76% male) were diagnosed with OAC. OAC incidence was 0.47% per annum and stable across three decades (1982-1991 0.56%, 1992-2001 0.46%, 2002-2012 0.41% (p=0.8)). All-cause mortality was increased for the whole cohort (SMR 163(95% CI 145-183)). Mortality from OAC appeared higher in patients who failed to attend surveillance (SMR 3216(95% CI 1543-5916)) compared with surveyed (SMR 1753(95% CI 933-2998)) and those unfit for surveillance due to co-morbidity (SMR 440(95% CI 143-1025)). Multivariable analysis identified low-grade dysplasia (HR 4.4(95% CI 1.56-12.43), p=0.005) and length of BO (HR 1.2(95% (1.1-1.3)), p<0.001)) as associated with OAC. Conclusions: Progression to OAC appeared stable over three decades at 0.47% per annum. Patients with BO had a modest increase in all-cause mortality and a large increase in OAC mortality, particularly if fit for surveillance. Low-grade dysplasia and the length of the BO segment were associated with developing OAC.
引用
收藏
页码:754 / 761
页数:8
相关论文
共 50 条
  • [1] Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus
    Holmberg, Dag
    Ness-Jensen, Eivind
    Mattsson, Fredrik
    El-Serag, Hashem B.
    Lagergren, Jesper
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 41 - 46
  • [2] Oesophageal adenocarcinoma and Barrett's oesophagus
    Das, Manjulika
    LANCET ONCOLOGY, 2016, 17 (12): : E524 - E524
  • [3] Barrett's oesophagus: Oesophageal adenocarcinoma incidence and risk factors
    Campbell, E
    Cooper, BT
    Riley, SA
    Trudgill, NJ
    GUT, 2004, 53 : A27 - A27
  • [4] Epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma
    Perez, Nancy
    Taylor, William
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2019, 35 (01) : 61 - 68
  • [5] RISK OF OESOPHAGEAL ADENOCARCINOMA IN NON-DYSPLASTIC BARRETT'S OESOPHAGUS
    Allam, M. M.
    Murray, G.
    Phull, P.
    GUT, 2017, 66 : A193 - A194
  • [6] OESOPHAGEAL CANCER RISK: RESULTS OF A PROSPECTIVE COHORT WITH BARRETT'S OESOPHAGUS
    Theron, B. T.
    Padmanabhan, H.
    Aladin, H.
    Cooper, B. T.
    Trudgill, N.
    GUT, 2012, 61 : A255 - A255
  • [7] Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
    Gregson, Eleanor M.
    Bornschein, Jan
    Fitzgerald, Rebecca C.
    BRITISH JOURNAL OF CANCER, 2016, 115 (04) : 403 - 410
  • [8] Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma
    Fitzgerald, R. C.
    GUT, 2006, 55 (12) : 1810 - 1818
  • [9] Genetic progression of Barrett’s oesophagus to oesophageal adenocarcinoma
    Eleanor M Gregson
    Jan Bornschein
    Rebecca C Fitzgerald
    British Journal of Cancer, 2016, 115 : 403 - 410
  • [10] A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma
    Schneider, Jennifer L.
    Corley, Douglas A.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (01) : 29 - 39